Skip to main content
PMC home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 2000 Jan;76(891):12–15. doi: 10.1136/pmj.76.891.12

Cerebral venous sinus thrombosis

H Allroggen 1, R Abbott 1
PMCID: PMC1741463  PMID: 10622773

Abstract

Cerebral venous sinus thrombosis is a challenging condition because of its variability of clinical symptoms and signs. It is very often unrecognised at initial presentation. All age groups can be affected. Large sinuses such as the superior sagittal sinus are most frequently involved. Extensive collateral circulation within the cerebral venous system allows for a significant degree of compensation in the early stages of thrombus formation. Systemic inflammatory diseases and inherited as well as acquired coagulation disorders are frequent causes, although in up to 30% of cases no underlying cause can be identified. The oral contraceptive pill appears to be an important additional risk factor. The spectrum of clinical presentations ranges from headache with papilloedema to focal deficit, seizures and coma. Magnetic resonance imaging with venography is the investigation of choice; computed tomography alone will miss a significant number of cases. It has now been conclusively shown that intravenous heparin is the first-line treatment for cerebral venous sinus thrombosis because of its efficacy, safety and feasability. Local thrombolysis may be indicated in cases of deterioration, despite adequate heparinisation. This should be followed by oral anticoagulation for 3-6 months. The prognosis of cerebral venous sinus thrombosis is generally favourable. A high index of clinical suspicion is needed to diagnose this uncommon condition so that appropriate treatment can be initiated.


Keywords: cerebral venous sinus thrombosis

Full Text

The Full Text of this article is available as a PDF (1.3 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ameri A., Bousser M. G. Cerebral venous thrombosis. Neurol Clin. 1992 Feb;10(1):87–111. [PubMed] [Google Scholar]
  2. Bousser M. G. Cerebral venous thrombosis: nothing, heparin, or local thrombolysis? Stroke. 1999 Mar;30(3):481–483. doi: 10.1161/01.str.30.3.481. [DOI] [PubMed] [Google Scholar]
  3. Bousser M. G., Chiras J., Bories J., Castaigne P. Cerebral venous thrombosis--a review of 38 cases. Stroke. 1985 Mar-Apr;16(2):199–213. doi: 10.1161/01.str.16.2.199. [DOI] [PubMed] [Google Scholar]
  4. Crawford S. C., Digre K. B., Palmer C. A., Bell D. A., Osborn A. G. Thrombosis of the deep venous drainage of the brain in adults. Analysis of seven cases with review of the literature. Arch Neurol. 1995 Nov;52(11):1101–1108. doi: 10.1001/archneur.1995.00540350095021. [DOI] [PubMed] [Google Scholar]
  5. Daif A., Awada A., al-Rajeh S., Abduljabbar M., al Tahan A. R., Obeid T., Malibary T. Cerebral venous thrombosis in adults. A study of 40 cases from Saudi Arabia. Stroke. 1995 Jul;26(7):1193–1195. doi: 10.1161/01.str.26.7.1193. [DOI] [PubMed] [Google Scholar]
  6. Deschiens M. A., Conard J., Horellou M. H., Ameri A., Preter M., Chedru F., Samama M. M., Bousser M. G. Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis. Stroke. 1996 Oct;27(10):1724–1730. doi: 10.1161/01.str.27.10.1724. [DOI] [PubMed] [Google Scholar]
  7. Einhäupl K. M., Villringer A., Meister W., Mehraein S., Garner C., Pellkofer M., Haberl R. L., Pfister H. W., Schmiedek P. Heparin treatment in sinus venous thrombosis. Lancet. 1991 Sep 7;338(8767):597–600. doi: 10.1016/0140-6736(91)90607-q. [DOI] [PubMed] [Google Scholar]
  8. Frey J. L., Muro G. J., McDougall C. G., Dean B. L., Jahnke H. K. Cerebral venous thrombosis: combined intrathrombus rtPA and intravenous heparin. Stroke. 1999 Mar;30(3):489–494. doi: 10.1161/01.str.30.3.489. [DOI] [PubMed] [Google Scholar]
  9. Gates P. C. Cerebral venous thrombosis. A retrospective review. Aust N Z J Med. 1986 Dec;16(6):766–770. doi: 10.1111/j.1445-5994.1986.tb00033a.x. [DOI] [PubMed] [Google Scholar]
  10. Horowitz M., Purdy P., Unwin H., Carstens G., 3rd, Greenlee R., Hise J., Kopitnik T., Batjer H., Rollins N., Samson D. Treatment of dural sinus thrombosis using selective catheterization and urokinase. Ann Neurol. 1995 Jul;38(1):58–67. doi: 10.1002/ana.410380112. [DOI] [PubMed] [Google Scholar]
  11. Kellett M. W., Martin P. J., Enevoldson T. P., Brammer C., Toh C. M. Cerebral venous sinus thrombosis associated with 20210A mutation of the prothrombin gene. J Neurol Neurosurg Psychiatry. 1998 Oct;65(4):611–612. doi: 10.1136/jnnp.65.4.611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kim S. Y., Suh J. H. Direct endovascular thrombolytic therapy for dural sinus thrombosis: infusion of alteplase. AJNR Am J Neuroradiol. 1997 Apr;18(4):639–645. [PMC free article] [PubMed] [Google Scholar]
  13. Ozsvath R. R., Casey S. O., Lustrin E. S., Alberico R. A., Hassankhani A., Patel M. Cerebral venography: comparison of CT and MR projection venography. AJR Am J Roentgenol. 1997 Dec;169(6):1699–1707. doi: 10.2214/ajr.169.6.9393193. [DOI] [PubMed] [Google Scholar]
  14. Preter M., Tzourio C., Ameri A., Bousser M. G. Long-term prognosis in cerebral venous thrombosis. Follow-up of 77 patients. Stroke. 1996 Feb;27(2):243–246. doi: 10.1161/01.str.27.2.243. [DOI] [PubMed] [Google Scholar]
  15. Provenzale J. M., Joseph G. J., Barboriak D. P. Dural sinus thrombosis: findings on CT and MR imaging and diagnostic pitfalls. AJR Am J Roentgenol. 1998 Mar;170(3):777–783. doi: 10.2214/ajr.170.3.9490973. [DOI] [PubMed] [Google Scholar]
  16. Smith T. P., Higashida R. T., Barnwell S. L., Halbach V. V., Dowd C. F., Fraser K. W., Teitelbaum G. P., Hieshima G. B. Treatment of dural sinus thrombosis by urokinase infusion. AJNR Am J Neuroradiol. 1994 May;15(5):801–807. [PMC free article] [PubMed] [Google Scholar]
  17. Vandenbroucke J. P. Cerebral sinus thrombosis and oral contraceptives. There are limits to predictability. BMJ. 1998 Aug 22;317(7157):483–484. doi: 10.1136/bmj.317.7157.483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Villringer A., Einhäupl K. M. Dural sinus and cerebral venous thrombosis. New Horiz. 1997 Nov;5(4):332–341. [PubMed] [Google Scholar]
  19. Villringer A., Mehraein S., Einhäupl K. M. Pathophysiological aspects of cerebral sinus venous thrombosis (SVT). J Neuroradiol. 1994 Apr;21(2):72–80. [PubMed] [Google Scholar]
  20. Vogl T. J., Bergman C., Villringer A., Einhäupl K., Lissner J., Felix R. Dural sinus thrombosis: value of venous MR angiography for diagnosis and follow-up. AJR Am J Roentgenol. 1994 May;162(5):1191–1198. doi: 10.2214/ajr.162.5.8166009. [DOI] [PubMed] [Google Scholar]
  21. Wang A. M. MRA of venous sinus thrombosis. Clin Neurosci. 1997;4(3):158–164. [PubMed] [Google Scholar]
  22. de Bruijn S. F., Stam J., Kappelle L. J. Thunderclap headache as first symptom of cerebral venous sinus thrombosis. CVST Study Group. Lancet. 1996 Dec 14;348(9042):1623–1625. doi: 10.1016/s0140-6736(96)07294-7. [DOI] [PubMed] [Google Scholar]
  23. de Bruijn S. F., Stam J., Koopman M. M., Vandenbroucke J. P. Case-control study of risk of cerebral sinus thrombosis in oral contraceptive users and in [correction of who are] carriers of hereditary prothrombotic conditions. The Cerebral Venous Sinus Thrombosis Study Group. BMJ. 1998 Feb 21;316(7131):589–592. doi: 10.1136/bmj.316.7131.589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. de Bruijn S. F., Stam J. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke. 1999 Mar;30(3):484–488. doi: 10.1161/01.str.30.3.484. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES